Terms ending in 2031
Every in-force patent on Purdue Pharma L.P.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,895,551 | Acrylamide Compounds and the Use Thereof In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US D785,196 | Laboratory Glassware Drying Rack In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 10,202,344 | Aryl Substituted Indoles and the Use Thereof In force · Low confidence | Purdue Pharma L.P. | In force | Low confidence | |
| US 9,279,003 | Analogs of Sodium Channel Peptide Toxin In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 9,120,752 | Pyridine Compounds as Sodium Channel Blockers In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 8,921,373 | Compounds Having TRPV1 Antagonistic Activity and Uses Thereof In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 9,549,972 | MHC-I Restricted Epitopes Containing Non-Natural Amino Acid Residues In force · Medium confidence | Purdue Pharma L.P. | In force | Medium confidence | |
| US 9,056,832 | Pyridine Compounds and the Uses Thereof In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 9,611,222 | Pyridine Compounds and the Uses Thereof In force · Low confidence | Purdue Pharma L.P. | In force | Low confidence | |
| US 10,149,896 | MHC-I Restricted Epitopes Containing Non-Natural Amino Acid Residues In force · Medium confidence | Purdue Pharma L.P. | In force | Medium confidence | |
| 13 more term ends in 2031 · Pro | |||||
10 of 23 patents shown. Soonest term end first, then patent number.
Pro members see all 23.
13 of these are in force and held by Purdue Pharma L.P..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.